Harbin Pharmaceutical Group Co., Ltd. (SHA:600664)
China
· Delayed Price · Currency is CNY 3.690
+0.010 (0.27%)
Apr 28, 2025, 2:45 PM CST
SHA:600664 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 16,208 | 16,176 | 15,400 | 13,755 | 12,741 | 10,741 | Upgrade
|
| Other Revenue | - | - | 56.21 | 53.63 | 61.06 | 47.59 | Upgrade
|
| Revenue | 16,208 | 16,176 | 15,457 | 13,809 | 12,802 | 10,788 | Upgrade
|
| Revenue Growth (YoY) | 3.45% | 4.65% | 11.93% | 7.86% | 18.66% | -8.76% | Upgrade
|
| Cost of Revenue | 11,703 | 11,607 | 11,443 | 10,446 | 9,826 | 8,543 | Upgrade
|
| Gross Profit | 4,505 | 4,569 | 4,013 | 3,363 | 2,976 | 2,245 | Upgrade
|
| Selling, General & Admin | 3,283 | 3,398 | 3,143 | 2,565 | 2,306 | 2,824 | Upgrade
|
| Research & Development | 142.29 | 136.43 | 106.02 | 115.81 | 97.73 | 92.53 | Upgrade
|
| Other Operating Expenses | 68.71 | 59.67 | 118.19 | 122.65 | 113.17 | 104.39 | Upgrade
|
| Operating Expenses | 3,494 | 3,594 | 3,393 | 2,805 | 2,528 | 3,049 | Upgrade
|
| Operating Income | 1,011 | 974.48 | 620.42 | 557.91 | 447.79 | -803.3 | Upgrade
|
| Interest Expense | - | - | -56.47 | -85.53 | -105.16 | -58.27 | Upgrade
|
| Interest & Investment Income | 12.44 | 12.44 | 51.58 | 69.19 | 16.5 | 50.42 | Upgrade
|
| Currency Exchange Gain (Loss) | - | - | -5.37 | 3 | 1.99 | -0.83 | Upgrade
|
| Other Non Operating Income (Expenses) | -21.96 | -12.87 | -22.74 | -19.44 | -5.07 | -176.52 | Upgrade
|
| EBT Excluding Unusual Items | 1,001 | 974.04 | 587.43 | 525.13 | 356.06 | -988.49 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -20 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 2.45 | 1.03 | 1.33 | 161.38 | 210.87 | 14.1 | Upgrade
|
| Asset Writedown | -102.01 | -100.07 | -15.49 | -32.52 | -2.33 | -74.72 | Upgrade
|
| Other Unusual Items | - | - | 77.26 | 67.17 | 65.93 | 80.47 | Upgrade
|
| Pretax Income | 901.6 | 875.01 | 650.54 | 701.15 | 630.53 | -968.65 | Upgrade
|
| Income Tax Expense | 182.58 | 184.4 | 176.32 | 188.94 | 220.69 | 76.6 | Upgrade
|
| Earnings From Continuing Operations | 719.03 | 690.61 | 474.22 | 512.21 | 409.85 | -1,045 | Upgrade
|
| Minority Interest in Earnings | -53.99 | -61.76 | -78.95 | -47.06 | -38.76 | -32.45 | Upgrade
|
| Net Income | 665.03 | 628.85 | 395.26 | 465.15 | 371.08 | -1,078 | Upgrade
|
| Net Income to Common | 665.03 | 628.85 | 395.26 | 465.15 | 371.08 | -1,078 | Upgrade
|
| Net Income Growth | 47.88% | 59.10% | -15.02% | 25.35% | - | - | Upgrade
|
| Shares Outstanding (Basic) | 2,550 | 2,515 | 2,470 | 2,448 | 2,474 | 2,506 | Upgrade
|
| Shares Outstanding (Diluted) | 2,550 | 2,515 | 2,470 | 2,584 | 2,474 | 2,506 | Upgrade
|
| Shares Change (YoY) | 2.39% | 1.82% | -4.40% | 4.46% | -1.29% | -10.19% | Upgrade
|
| EPS (Basic) | 0.26 | 0.25 | 0.16 | 0.19 | 0.15 | -0.43 | Upgrade
|
| EPS (Diluted) | 0.26 | 0.25 | 0.16 | 0.18 | 0.15 | -0.43 | Upgrade
|
| EPS Growth | 44.43% | 56.25% | -11.11% | 20.00% | - | - | Upgrade
|
| Free Cash Flow | 492.76 | 691.69 | 863.14 | 532.45 | -239.13 | -846.37 | Upgrade
|
| Free Cash Flow Per Share | 0.19 | 0.28 | 0.35 | 0.21 | -0.10 | -0.34 | Upgrade
|
| Gross Margin | 27.79% | 28.24% | 25.96% | 24.35% | 23.24% | 20.81% | Upgrade
|
| Operating Margin | 6.24% | 6.02% | 4.01% | 4.04% | 3.50% | -7.45% | Upgrade
|
| Profit Margin | 4.10% | 3.89% | 2.56% | 3.37% | 2.90% | -9.99% | Upgrade
|
| Free Cash Flow Margin | 3.04% | 4.28% | 5.58% | 3.86% | -1.87% | -7.85% | Upgrade
|
| EBITDA | 1,250 | 1,215 | 867.64 | 821.32 | 716.99 | -433.54 | Upgrade
|
| EBITDA Margin | 7.71% | 7.51% | 5.61% | 5.95% | 5.60% | -4.02% | Upgrade
|
| D&A For EBITDA | 239.15 | 240.76 | 247.21 | 263.41 | 269.2 | 369.75 | Upgrade
|
| EBIT | 1,011 | 974.48 | 620.42 | 557.91 | 447.79 | -803.3 | Upgrade
|
| EBIT Margin | 6.24% | 6.02% | 4.01% | 4.04% | 3.50% | -7.45% | Upgrade
|
| Effective Tax Rate | 20.25% | 21.07% | 27.10% | 26.95% | 35.00% | - | Upgrade
|
| Revenue as Reported | - | - | 15,457 | 13,809 | 12,802 | 10,788 | Upgrade
|
| Advertising Expenses | - | - | 1,574 | 1,058 | 340.89 | 201.29 | Upgrade
|
Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.